Non-depolarizing cardioplegia activates Ca2+-ATPase in sarcoplasmic reticulum after reperfusion

European Journal of Cardio-thoracic Surgery

Volumn 22, Issue 6, 2002, Pages 951-956

  Watanabe, Masazumi ^a,b   Egi, Koso ^a   Shimizu, Masato ^a   Nakahara, Hideki ^a   Tanaka, Hiroyuki ^a   Sakamoto, Tohru ^a   Sunamori, Makoto ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

Author keywords

Ca2+ ATPase; CAMP; CGMP; Non depolarizing cardioplegia

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BUFFER; CARDIOPLEGIC AGENT; CYCLIC AMP; CYCLIC GMP; LIDOCAINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CARDIOPLEGIA; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART CYCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; TISSUE LEVEL;

ANIMALS; CALCIUM-TRANSPORTING ATPASES; CYCLIC AMP; CYCLIC GMP; HEART ARREST, INDUCED; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL REPERFUSION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM;

EID: 0036899989     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00582-1     Document Type: Article

References (26)

1. Lopez J.R., Jahangir R., Jahangir A., Shen W.K., Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg. 112:(3):1996;820-831.
2. Kloner R.A., Przyklenk K., Kay G.L. Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Card Surg. 9:(3 Suppl):1994;397-402.
3. McKenney P.A., Apstein C.S., Mendes L.A., Connelly G.P., Aldea G.S., Shemin R.J., Davidoff R. Increased left ventricular diastolic chamber stiffness immediately after coronary artery bypass surgery. J Am Coll Cardiol. 24:(5):1994;1189-1194.
4. 2+ waves: a laser confocal microscopy study. Am J Physiol. 270:(4 Pt 2):1996;H1384-H1389.
5. Sunamori M., Shimizu M., Tabuchi N., Arai H., Tanaka H. The use of a nondepolarizing cardioplegic solution for cardiac preservation has a beneficial effect on the left ventricular diastolic function. Transplant Int. 14:(2):2001;72-79.
6. Jones L.R., Besch H.R. Jr., Fleming J.W., McConnaughey M.M., Watanabe A.M. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. J Biol Chem. 254:(2):1979;530-539.
7. 2+-stimulated ATPase activity. Anal Biochem. 157:1986;375-380.
8. Henkel R.D., VandeBerg J.L., Walsh R.A. A microassay for ATPase. Anal Biochem. 169:1988;312-318.
9. Gay W.A. Jr. Crystalloid potassium cardioplegia: concepts and early studies. Ann Thorac Surg. 58:(4):1994;1285-1286.
10. Eucher P.M., Buche M., Broka S., Schoevaerdts J.C. Retrieval of crystalloid cardioplegic solutions. Ann Thorac Surg. 61:(2):1996;746-747.
11. Dorman B.H., Hebbar L., Hinton R.B., Roy R.C., Spinale F.G. Preservation of myocyte contractile function after hyperthermic cardioplegic arrest by activation of ATP-sensitive potassium channels. Circulation. 96:(7):1997;2376-2384.
12. O'Brien P.J., Shen H., Ianuzzo S., Cane M.E., McGrath L.B., Ianuzzo C.D. Enhancement of calcium cycling by atrial sarcoplasmic reticulum after cardiopulmonary bypass and cardioplegia during open heart surgery. Can J Physiol Pharmacol. 75:(2):1997;143-152.
13. 2+ gradient across the sarcoplasmic reticulum in perfused rabbit heart. A 19F nuclear magnetic resonance study. Circ Res. 83:(9):1998;898-907.
14. Schmidt U., Hajjar R.J., Helm P.A., Kim C.S., Doye A.A., Gwathmey J.K. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol. 30:(10):1998;1929-1937.
15. 2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med. 74:(6):1996;321-332.
16. Mubagwa K., Kaplan P., Shivalkar B., Miserez M., Leunens V., Borgers M., Flameng W. Calcium uptake by the sarcoplasmic reticulum, high energy content and histological changes in ischemic cardiomyopathy. Cardiovasc Res. 37:(2):1998;515-523.
17. 2+-channel activation by ischemia/reperfusion. Mol Cell Biochem. 173:(1-2):1997;135-143.
18. Halow J.M., Figueredo V.M., Shames D.M., Camacho S.A., Baker A.J. Role of slowed Ca(2+) transient decline in slowed relaxation during myocardial ischemia. J Mol Cell Cardiol. 31:(9):1999;1739-1748.
19. 2+-ATPase of the ischemic-reperfused myocardium: protective effect of hypocalcemia on calmodulin-stimulated activity. Life Sci. 62:(1):1998;29-36.
20. Cooper D.M., Schell M.J., Thorn P., Irvine R.F. Regulation of adenylyl cyclase by membrane potential. J Biol Chem. 273:(42):1998;27703-27707.
21. Beltran C., Zapata O., Darszon A. Membrane potential regulates sea urchin sperm adenylylcyclase. Biochemistry. 35:(23):1996;7591-7598.
22. Movsesian M.A. Calcium uptake by sarcoplasmic reticulum and its modulation by cAMP-dependent phosphorylation in normal and failing human myocardium. Basic Res Cardiol. 87:(Suppl 1):1992;277-284.
23. 2+ release from microsomal vesicles of rat parotid acinar cells. Biochem Biophys Res Commun. 246:(2):1998;422-425.
24. 2+ extrusion from human platelets. Biochim Biophys Acta. 1105:(1):1992;19-28.
25. 2+-ATPase activity in rat megakaryocytes. Eur J Pharmacol. 347:(2-3):1998;355-361.
26. 2+-ATPase by nitric oxide. FEBS Lett. 440:(1-2):1998;218-222.